Pharmacology Lecture: Key Medications Overview

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/33

flashcard set

Earn XP

Description and Tags

Vocabulary flashcards summarizing the mechanism of action, primary therapeutic use, and key safety considerations for each drug covered in the lecture.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

34 Terms

1
New cards

Baclofen

GABA-B receptor agonist that relaxes skeletal muscle for spasticity (e.g., MS, spinal injury); can cause CNS depression—taper slowly to prevent withdrawal.

2
New cards

Donepezil

Acetylcholinesterase inhibitor that raises brain acetylcholine to manage Alzheimer’s disease; diarrhea, insomnia, and bradycardia are common.

3
New cards

Interferon beta-1a

Immunomodulatory cytokine that lessens CNS inflammation in multiple sclerosis; flu-like reactions, depression, and elevated LFTs require monitoring.

4
New cards

Levodopa/Carbidopa

Levodopa converts to dopamine while Carbidopa blocks peripheral conversion, improving Parkinson’s symptoms; nausea and orthostatic hypotension may occur.

5
New cards

Memantine

NMDA receptor antagonist used in moderate-severe Alzheimer’s disease to curb excitotoxicity; dizziness and confusion possible—dose adjust in renal impairment.

6
New cards

Phenytoin

Voltage-gated sodium channel blocker for seizure control; gingival hyperplasia, ataxia, and rash signal toxicity—check serum levels.

7
New cards

Sumatriptan

5-HT1B/1D receptor agonist producing cranial vasoconstriction to abort acute migraine; chest tightness and contraindications in CVD apply.

8
New cards

Valproic Acid

Elevates GABA to act as broad-spectrum anticonvulsant and mood stabilizer; hepatotoxicity, weight gain, and tremor warrant LFT monitoring.

9
New cards

Methotrexate

Folate antagonist inhibiting DNA synthesis for RA, psoriasis, and cancers; bone-marrow suppression and hepatotoxicity necessitate CBC/LFT checks.

10
New cards

Raloxifene

Selective estrogen receptor modulator that preserves bone in postmenopausal osteoporosis; hot flashes and thromboembolic risk are notable.

11
New cards

Albuterol

Short-acting β2-adrenergic agonist providing rapid bronchodilation in asthma attacks; tremor and tachycardia are common side effects.

12
New cards

Alprazolam

Benzodiazepine that enhances GABA-A activity for anxiety and panic disorders; sedation and dependence potential require caution.

13
New cards

Amitriptyline

Tricyclic antidepressant blocking serotonin and norepinephrine reuptake, used for depression and neuropathic pain; anticholinergic effects and orthostatic hypotension seen.

14
New cards

Betaxolol

Selective β1-blocker lowering IOP and BP for glaucoma or hypertension; may cause bradycardia and fatigue—use cautiously in asthma.

15
New cards

Chlorpromazine

First-generation antipsychotic inhibiting dopamine receptors, treating schizophrenia and severe nausea; EPS, sedation, and NMS monitoring needed.

16
New cards

Fluoxetine

SSRI enhancing synaptic serotonin for depression, anxiety, and OCD; nausea, insomnia, and serotonin syndrome risk.

17
New cards

Lithium

Mood stabilizer modulating serotonin for bipolar disorder; narrow therapeutic index—tremor, polyuria, and hypothyroidism require level checks.

18
New cards

Pilocarpine

Muscarinic agonist stimulating secretions and lowering IOP; used for glaucoma and xerostomia, may cause sweating and bradycardia.

19
New cards

Timolol

Non-selective β-blocker eye drops that reduce aqueous humor for glaucoma; can induce bronchospasm or bradycardia—contraindicated in asthma.

20
New cards

Venlafaxine

SNRI boosting serotonin and norepinephrine to treat depression and anxiety; hypertension and insomnia warrant BP monitoring.

21
New cards

Acetaminophen

Central prostaglandin synthesis inhibitor used for pain and fever; overdose causes hepatotoxicity—limit to 4 g/day.

22
New cards

Allopurinol

Xanthine oxidase inhibitor decreasing uric acid production for gout prophylaxis; rash and hypersensitivity possible—adjust in renal impairment.

23
New cards

Celecoxib

Selective COX-2 inhibitor for osteoarthritis and RA pain; fewer GI ulcers but higher cardiovascular risk.

24
New cards

Aspirin

Irreversible COX inhibitor providing analgesia, anti-inflammation, and antiplatelet action; GI bleeding and Reye’s syndrome caution.

25
New cards

Morphine

Opioid μ-receptor agonist for moderate-severe pain; watch for respiratory depression, constipation, and dependence.

26
New cards

Naloxone

Competitive opioid antagonist reversing overdose; may precipitate withdrawal and often requires repeat dosing due to shorter half-life.

27
New cards

Prednisone

Systemic corticosteroid suppressing inflammation and immunity; can cause hyperglycemia, osteoporosis—must taper to prevent adrenal crisis.

28
New cards

Tramadol

Weak opioid and SNRI analgesic for moderate pain; lowers seizure threshold and carries serotonin syndrome risk.

29
New cards

Beclomethasone

Inhaled corticosteroid decreasing airway inflammation in asthma/COPD; oral thrush and hoarseness—rinse mouth post-use.

30
New cards

Cromolyn

Mast-cell stabilizer preventing histamine release for asthma and allergic rhinitis prophylaxis; not useful in acute attacks.

31
New cards

Dextromethorphan

Central antitussive suppressing cough reflex; dizziness and potential misuse at high doses—avoid alcohol.

32
New cards

Montelukast

Leukotriene receptor antagonist for asthma maintenance and allergic rhinitis; headache and mood changes, monitor for suicidality.

33
New cards

Diphenhydramine

First-generation H1 antihistamine for allergy relief and insomnia; drowsiness and anticholinergic effects, avoid in elderly fall-risk.

34
New cards

Codeine

Opioid agonist pro-drug providing mild-moderate analgesia and cough suppression; constipation and respiratory depression—contraindicated in children.